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Abstract
This study investigated the antimicrobial and osteogenic properties of titanium (Ti) disks 
superficially modified with tetracycline (TCH)-incorporated polymer nanofibers. The experiments 
were carried out in two phases. The first phase dealt with the synthesis and characterization (i.e., 
morphology, mechanical strength, drug release, antimicrobial activity, and cytocompatibility) of 
TCH-incorporated fibers. The second phase was dedicated to evaluating both the antimicrobial and 
murine-derived osteoprecursor cell (MC3T3-E1) response of Ti-modified with TCH-incorporated 
fibers. TCH was successfully incorporated into the submicron-sized and cytocompatible fibers. All 
TCH-incorporated mats presented significant antimicrobial activity against periodontal pathogens. 
The antimicrobial potential of the TCH-incorporated fibers-modified Ti was influenced by both 
the TCH concentration and bacteria tested. At days 5 and 7, a significant increase in MC3T3-E1 
cell number was observed for TCH-incorporated nanofibers-modified Ti disks when compared to 
that of TCH-free nanofibers-modified Ti-disks and bare Ti. A significant increase in alkaline 
phosphatase (ALP) levels on the Ti disks modified with TCH-incorporated nanofiber on days 7 
and 14 was seen, suggesting that the proposed surface promotes early osteogenic differentiation. 
Collectively, the data suggest that TCH-incorporated nanofibers could function as an antimicrobial 
surface modifier and osteogenic inducer for Ti dental implants.
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For over four decades, commercially pure titanium (cpTi) and titanium (Ti) alloys have been 
used for implant therapy due to their remarkable mechanical properties in load-bearing 
applications, low density, high corrosion resistance, and biocompatibility.1 Of note, the basis 
for using Ti in implant dentistry is predicated on its ability to achieve a direct structural and 
functional interface with living bone (i.e., osseointegration), which has allowed for the 
successful restoration of masticatory function in partially and completely edentulous 
patients.2, 3 Regrettably, despite accumulating evidence regarding the positive role played by 
implant surface modification both texture/microstructure and chemistry on bone 
integration4–7, the risk of infection (peri-implantitis), and thus early implant loss8, 9, still 
embodies a major clinical concern.
Peri-implantitis has been defined as a progressive and irreversible polymicrobial infection 
affecting soft and hard tissues around dental implants. It is well-established that subgingival 
anaerobic Gram-negative bacteria such as Prevotella intermedia, Prevotella nigrescens, 
Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Treponema denticola, 
and Tannerella forsythia bacteria associated with peri-implantitis are similar to those related 
to periodontal disease.8, 9 Simply speaking, once peri-implantitis is established, one needs to 
focus on the decontamination of the implant surfaces, control of inflammation, and 
inhibition of progressive bone loss. Over the years, apart from the non-surgical and surgical 
approaches performed to manage the disease, alternative and/or complementary treatment 
strategies such as those involving laser and photodynamic therapies have been investigated.
Significant advances in nanotechnology have helped to pave the way toward the 
development of antimicrobial coatings that could be used to avoid implant infection.10–13 
Meanwhile, recent research highlighted the prospective anabolic effects associated with 
tetracycline-derivatives (e.g., doxycycline and minocycline) as their use seemed to enhance 
cell proliferation.14 Nonetheless, and to the best of our knowledge, no single dental implant 
that conjugates bone promoting and antimicrobial surface properties derived from 
tetracycline-derivatives is available. In recent years, electrospinning has been deemed a 
facile approach to synthesize antibiotic-containing polymer nanofibers with significant 
antimicrobial properties15, 16 and ability to prevent bacterial infection.17, 18 Worth 
mentioning, electrospinning has demonstrated to be a potential method to modify the surface 
of titanium implants with nanofibers as a coating material, contributing to potentially 
minimize early implant loss, especially in those patients who are at high risk of periodontal 
disease.
The purpose of this study was to investigate the antimicrobial and osteogenic properties of 
titanium (Ti) dental implant disks superficially modified with tetracycline (TCH)-
incorporated polymer nanofibers.
MATERIALS AND METHODS
The experiments were carried out in two phases. The first phase dealt with the synthesis and 
characterization (i.e., morphology, mechanical strength, antimicrobial activity, and 
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cytocompatibility) of TCH-incorporated polymer fibers. The second phase was dedicated to 
evaluating both the antimicrobial and biological osteoprecursor cell response (i.e., 
proliferation and differentiation) of TCH-incorporated fibers-modified Ti.
Phase I
Reagents—Poly(DL-lactide) (PLA, inherent viscosity: 0.55-0.75 dL/g in CHCl3) and 
poly(ε-caprolactone) (PCL, inherent viscosity: 1.29 dL/g in CHCl3) were purchased from 
Lactel Absorbable Polymers (Durect Corporation, Birmingham, AL, USA). Type-B Gelatin 
(GEL) from bovine skin (bloom no. 225), tetracycline hydrochloride (TCH, molecular 
weight [Mw] 480.90 g/mol), hexamethyldisilazane (HMDS), formaldehyde, and 1,1,1,3,3,3-
hexafluoro-2-propanol (HFP) were acquired from Sigma-Aldrich (St. Louis, MO). Brain 
heart infusion (BHI) culture media containing 5 g/L yeast extract (BHI-YE) with 5% v/v 
Vitamin K/hemin solution were obtained from Difco Laboratories (Detroit, MI) and Thermo 
Scientific (Pittsburgh, PA), respectively. Phosphate-buffered saline, ethanol, and blood agar 
plates supplemented with 5% sheep blood were obtained from Thermo Fisher Scientific 
(Fair Lawn, NJ).
Synthesis and characterization of TCH-incorporated polymer fibers—A polymer 
solution was prepared by solubilizing PLA, PCL, and gelatin/GEL (ratio of 2:2:1, w/w) in 
HFP to obtain a 7.5 wt.% solution. Next, TCH) was added to the polymer solution at 
different concentrations (5, 10, and 25 wt.%, relative to the total polymer weight) and stirred 
overnight. Then, each solution was individually loaded into a plastic syringe (Beckton-
Dickson, Franklin Lakes, NJ, USA) fitted with a 27G metallic blunt-tip needle and spun into 
fibrous mats using the following electrospinning parameters: 1.0 mL.h−1, 18 cm distance, 
and 20-25 kV. To ensure complete elimination of any residual solvent, the processed fibrous 
mats were dried for 48 h under vacuum at room temperature (RT) and then stored at 4°C 
prior to use.15
The processed fibers were characterized by morphological, chemical, mechanical, drug 
release, antimicrobial, and cytotoxicity analyses following previously established 
protocols.15 For the morphological analysis, samples were taken from each mat, mounted on 
Al stubs, sputter-coated with Au-Pd, and imaged using a scanning electron microscope 
(SEM, JSM-5310LV, JEOL, Tokyo, Japan). Fourier transform infrared (FTIR) spectroscopy 
in attenuated total reflection mode (ATR/FTIR-4100, JASCO, Easton, MD, USA) was used 
to evaluate the possibility of an interaction of chemical bonds between TCH and the 
polymers. For the mechanical analyses, samples were tested using tensile testing (expert 
5601, ADMET, Norwood, MA, USA), under dry and hydrated (24 h in PBS) conditions.15 
For the drug release analysis, high-performance liquid chromatography (HPLC) was 
conducted. TCH-incorporated mats (15 × 15 mm2, n=4/group) were weighed and incubated 
in 10 mL of PBS at 37°C. 1 mL aliquots were collected at different time points. Equal 
amounts of fresh PBS were added back to the incubation media following aliquot retrieval. 
The TCH content (absorption peak 276.8 nm) was determined using HPLC equipped with a 
UV-Vis detector (Perkin-Elmer, Shelton, CT, USA). TCH solutions at known concentrations 
were used to obtain the calibration curves.15
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Antimicrobial properties of electrospun TCH-incorporated polymer fibers—The 
antimicrobial activity of the fibrous mats was assessed against Aggregatibacter 
actinomycetemcomitans (Aa, ATCC 29522), Fusobacterium nucleatum (Fn, ATCC 10953), 
Porphyromonas gingivalis (Pg, ATTC 33277), and Prevotella intermedia (Pi, ATCC 25611) 
using the agar diffusion assay. All bacteria were cultivated in Brain Heart Infusion (BHI) 
broth supplemented with 5 g yeast extract/L and 5% v/v vitamin K+ hemin (BHI-YE; 
Becton, Dickinson and Company) at 37°C in an anaerobic GasPak jar for 24 h. After that, 
100 µL was pipetted onto blood agar plates, spread and placed in an incubator under 
anaerobic conditions. Subsequently, the fibrous mats (ϕ= 5 mm, n=3/group) were ultraviolet 
(UV)-irradiated for disinfection purposes and placed on cultured blood agar plates 
containing bacterial lawns of Aa, Fn, Pg, and Pi. After 5 days of incubation the inhibition 
zones were measured (in mm) using a transparent plastic ruler.15, 20
Cytocompatibility of TCH-incorporated polymer fibers—Mouse calvaria-derived 
osteoprecursor cells (MC3T3-E1, American Type Culture Collection, ATCC, CRL-2593, 
Manassas, VA, USA) were cultured in minimum essential medium (MEM, GIBCO/
Invitrogen, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (HyClone 
Laboratories Inc., South Logan, UT, USA), 1% L-glutamine (Hyclone), and 1% penicillin–
streptomycin (Sigma) in a humidified incubator at 37°C, with 5% CO2.21 Replacement of 
the culture medium was performed every other day. MC3T3-E1 cells at passages 15-17 were 
used. Cytotoxicity assays were performed according to the guidelines (10993-5) provided by 
the International Standards Organization.22 Briefly, electrospun mats (15 × 15 mm2) were 
disinfected by UV irradiation (30 min/side) and then incubated in culture media (1 cm2/mL) 
for 48 h at 37°C. The extracts were filtered through a membrane (Millipore®) and serially 
diluted (100, 50, 25, 12.5 and 6.25%). A 0.3% phenol solution was assayed to serve as the 
positive control. MC3T3-E1 cells were seeded on 96-well plates at a density of 3000 
cells/mL, and were allowed to attach. After 4 h, the media was replaced by the distinct 
extract dilutions obtained from the electrospun mats, negative, and positive controls. 100 µL 
of each extract was dispensed into each well. Control columns of four wells were prepared 
with a medium without cells (blank), and a medium with cells but without the extract (100% 
survival). The microplate was then incubated under 5% CO2 humidified atmosphere. After 
72 h, 20 μL of CellTiter 96 AQueous One Solution Reagent (Promega, Madison, WI, USA) 
was added to the test wells and allowed to react for 2 h (37°C and 5% CO2). Incorporated 
dye was measured by reading the absorbance at 490 nm in a microplate reader against a 
blank column.15 Results are shown as the mean value (±SD) of the mean.
Phase II
TCH-incorporated fiber-modified Ti - antimicrobial and cell-related studies—
Commercially pure Ti disks (12-mm diameter and 1-mm thick) were procured from United 
Titanium, Inc. (Wooster, OH, USA), cleaned overnight by sonication with deionized water, 
dried in air, mounted on a stainless steel aluminum foil-covered mandrel, and modified by 
TCH-incorporated fibers using the aforementioned electrospinning parameters for ca. 8 min. 
The antimicrobial activity of the TCH-incorporated fiber-modified Ti (n=3/group) was 
evaluated against Aa, Fn, Pg, and Pi using the agar diffusion protocol, as previously 
described.
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Cell proliferation (n=4/group) was assessed using the WST-1® (Roche Diagnostics 
Corporation, Indianapolis, IN, USA) assay after 1, 3, 5, and 7 days. All samples were UV-
sterilized before cell seeding. In brief, 1×104 cells at passage 15 were seeded on each of the 
Ti disks in 24-well culture plates. The media was changed every other day. On the day of 
analysis, 30 µL of the assay reagent was added to 300 µL of media in each well and allowed 
to react for 3 h at 37°C and 5% CO2. The incorporated dye was then measured by reading 
the absorbance at 450 nm in a microplate reader against the blank. Additional samples (N=2) 
were included to qualitatively evaluate the morphology of the cells via SEM. Following 
samples’ removal from the culture medium, they were fixed in buffered 4% formaldehyde 
(Sigma) and washed with PBS to remove unbound cells. Next, the samples were dehydrated 
using ethanol gradients, soaked in ethanol/hexamethyldisilazane (HMDS) gradients, and 
then incubated in 100% HMDS.15 Upon air-drying; the samples were mounted on Al stubs 
and sputter-coated with Au-Pd prior to imaging.
MC3T3-E1 cells osteogenic differentiation on the TCH-incorporated nanofiber-modified Ti 
disks was quantitatively determined by alkaline phosphatase (ALP) activity at days 1, 3, 7, 
and 14 using an ALP assay kit (SensoLyte pNPP, AnaSpec, Fremont, CA, USA). The assay 
is based on the conversion of p-nitrophenyl phosphate (pNPP) to p-nitrophenol by the 
enzyme. Briefly, the cells were seeded on the nanofiber-modified Ti disks (n=4) at a density 
of 3×106 and cultured in osteogenic differentiation media (Lonza, Walkersville, MD, USA) 
for 14 days. On specific days, the cells were digested using lysis buffer (200 µL) and 
subjected to freeze-thaw cycles. The cell suspension was centrifuged for 10 min at 4°C. 50 
µL of the supernatant was added to each well of a 96-well plate and allowed to react for 15 
min with the pNPP substrate solution (50 µL) at 37°C. Standards of 0–300 ng/mL p-
nitrophenol were run in parallel. The absorbance of standards and samples were read at 405 
nm. Protein concentrations of the sample supernatants were determined using a Pierce™ 
assay kit (Thermo Scientific, Waltham, MA, USA).
STATISTICAL ANALYSIS
Data were statistically analyzed (SigmaPlot, version 12, Systat Software, Inc., San Jose, CA, 
USA) using One-Way (for fiber diameter, cytotoxicity, and antimicrobial [of nanofiber-
modified Ti disks] data) or Two-Way (for mechanical, antimicrobial [of nanofibers], and cell 
proliferation data) Analysis of Variance and Tukey’s test for multiple comparisons. A 5% 
significance level was used for all analyses.
RESULTS
Phase I
According to Figure 1A, all electrospun mats demonstrated a smooth and bead-free fibrous 
architecture regardless of the presence and concentration of TCH. The diameter of the fibers 
increased with TCH incorporation, although only at 25 wt.%, which resulted in a higher (p < 
0.05) diameter when compared to the other groups. With regard to the fiber diameter 
distribution, the TCH-free mat displayed the most homogeneous and narrow distribution 
(Figure 1B). Moreover, TCH was successfully incorporated (FTIR data, Figure 1C) into the 
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fibers, confirmed by the presence of characteristic peaks (1,615 cm−1 and 1,581 cm−1) 
observed within the TCH powder and TCH-incorporated mats.
Results regarding mechanical performance of the mats are presented in Figure 2. There was 
a statistically significant (p≤0.001) interaction between the factors “electrospun mat” and 
“storage condition,” except for tensile strength (p=0.981). Overall, while the incorporation 
of a low (5 wt.%) TCH amount did not alter the mechanical properties, the addition of 
medium (10 wt.%) and high (25 wt.%) TCH contents seemed to improve the evaluated 
properties, particularly the Young’s modulus. The only exception was seen for the 
elongation at break, which, under dry conditions, was progressively reduced with increased 
TCH content (p < 0.05).
As shown in Figure 3, TCH was mostly released within the first 24 h, with the more 
concentrated groups releasing a greater TCH amount—followed by a slow and continuous 
release up to 7 days. Based on the results shown in Figure 4A, all TCH-incorporated mats 
presented significant antimicrobial activity, producing even higher (p < 0.05) inhibition 
zones than the control (chlorhexidine). Noteworthy, Pg and Pi, respectively, demonstrated 
the highest and the lowest susceptibility to TCH. The cell viability data (Figure 4B) 
indicated that all electrospun mats were considered biologically safe when compared to the 
phenol solution (positive control).
Phase II
The antimicrobial potential of the TCH-incorporated nanofibers-modified Ti disks was 
influenced by both the TCH concentration and bacteria specie investigated (Figure 5). When 
tested against Aa and Fn, the greater the TCH concentration, the greater the antimicrobial 
activity (p < 0.05); nevertheless, when tested against Pg and Pi, TCH concentrations beyond 
10 wt.% did not enhance antimicrobial activity (p > 0.05).
Results regarding cell proliferation are given in Figure 6A. A consistent increase in cell 
proliferation was seen from day 1 to day 7. At days 5 and 7, a significant increase in cell 
number was observed for TCH-incorporated nanofibers-modified Ti disks when compared to 
that of TCH-free nanofibers-modified Ti-disks and bare Ti. Meanwhile, ALP activity was 
similar for all groups at days 1 and 3 (Figure 6B). However, there was a significant increase 
in ALP levels of MC3T3-E1 cells on Ti disks modified with TCH-incorporated nanofibers 
(5, 10, and 25 wt.%) on days 7 and 14, suggesting that the proposed surface modification 
promotes early osteogenic differentiation when compared to both TCH-free and bare Ti 
groups. The ALP activity decreased by day 14 in all the samples, indicating the onset of the 
ECM mineralization phase (Figure 6B). There was no statistically significant difference in 
ALP levels among the TCH-incorporated fibers-modified Ti. Representative SEM images 
further demonstrated that all Ti-disks supported cell adhesion, spreading, and proliferation 
(Figure 7).
DISCUSSION
The present research holds potential clinical relevance, since there is strong evidence 
concerning the failure rate of implants in periodontally-compromised individuals8, 9, clearly 
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stressing the need for an implant surface with antimicrobial characteristics to prevent and/or 
fight pathogens.
In this investigation, TCH-incorporated nanofibers were successfully synthesized via 
electrospinning. The presence of TCH did not negatively affect the architecture and 
morphology of the fibers (Figure 1A). Although a slight increase in fiber diameter occurred 
upon TCH incorporation (Figure 1B), especially for the most concentrated group (~ 64.3%), 
this increase seemed not to compromise the applicability of the fibers, since they were still 
homogeneous and within the submicron-sized range. Indeed, one could expect that the 
hydroxyl groups present in the molecular structure of TCH would increase the 
intermolecular interactions (e.g., hydrogen bonds) with the polymer, or the viscosity of the 
polymer solution, thus resulting in thicker fibers.
Regarding the mechanical performance of the fibrous mats, the tensile strength was not 
affected by the presence/concentration of TCH and storage conditions (Figure 2), and this 
may be a reason for the similar fiber morphology exhibited by all mats. Conversely, TCH 
concentration played a role in the other properties tested: while the Young’s modulus 
improved with greater TCH content, the elongation at break was significantly reduced. It can 
be suggested that on one hand, the presence of TCH may produce strong fibers (i.e., high 
Young’s modulus), probably due to the formation of intermolecular interactions or an 
enhanced crystallization effect; on the other hand, TCH may turn the fiber brittle, reducing 
its stretching ability. Nonetheless, it is worth mentioning that upon immersion into PBS, a 
significant increase in elongation at break and significant decrease in Young’s modulus were 
observed, probably due to the burst release of TCH from the fibers (Figure 3). The increase 
in stretching ability under wet conditions would be of utmost importance for the applications 
of the obtained fibers as a coating, especially because dental implants are commonly 
screwed into the bone which may evoke bleeding (wet environment).
Gelatin, a natural polymer that can be obtained by denaturing collagen, has shown nearly 
identical composition and biological properties to that of collagen.23 Recently, blends of 
GEL and synthetic polymers were spun into fibrous scaffolds as potential skin grafts. It was 
demonstrated that increasing the GEL content led to quicker fibers degradation.24 Based on 
the aforementioned, we hypothesized that the addition of GEL to the highly hydrophobic 
polymer blend (PLA:PCL) would lead to an increased solubility and quicker degradation, 
which could ultimately translate into faster TCH release. It has been known that upon 
implantation, a competition exists between implant integration and bacterial adhesion to the 
biomaterial surface.25 Notably, a 6 h post-implantation period has been deemed crucial to 
the long-term success of an implantable device. Collectively, the microbiological data (i.e., 
TCH-incorporated mats and TCH-incorporated fibers-modified Ti disks) demonstrated 
significant antimicrobial properties against peri-implantitis-related pathogens.
Our cell viability data revealed that the TCH amounts released by the electrospun mats were 
not cytotoxic. More importantly, since the levels of TCH used might have played both a 
direct and indirect role in cell viability, we evaluated the effects of the TCH-incorporated 
nanofiber-modified Ti disks on the proliferation and differentiation of osteoprecursor 
(MC3T3-E1) cells. As previously stated, an increased cell proliferation at day 7 on TCH-
Bottino et al. Page 7





















incorporated nanofiber-modified Ti was seen when compared to the control (bare Ti). 
Previous work by Gomes et al.14 evaluated the dose-dependency effects of tetracyclines on 
human bone marrow cells. It was found that continuous exposure to doxycycline (1 and 5 
µg/mL) and minocycline (1-10 µg/mL) caused an evident induction of cell proliferation from 
the first week onward. However, higher concentrations of doxycycline and minocycline 
negatively impact cell growth. In our study, the amount of TCH released led to increased cell 
proliferation. Meanwhile, to test our second hypothesis, MC3T3-E1 differentiation was 
assessed by ALP activity, an early marker of osteoblastic cell differentiation, which is 
divided into three phases: proliferation, maturation, and ECM mineralization. The highest 
enzyme level is found during the maturation phase (the second stage) of differentiation. 
Although an increased ALP expression was seen during the maturation phase (Day 7) on 
TCH-incorporated fibers-modified Ti, it is worth stating here that conflicting results have 
been reported on the effect of tetracyclines (minocycline, doxycycline, and tetracycline 
hydrochloride) on osteogenic differentiation. Overall, the higher the dose, the greater the 
inhibition on preosteoblasts differentiation and bone-related protein expression (e.g., bone 
morphogenic protein-2).26 In this way, recent research reported positive effects when using 
small doses of doxycycline (0.1 and 1.0 mM) on osteoprecursor cells differentiation at an 
early stage.27 Furthermore, osteoinductive effects were also seen upon treatment, which was 
attributed to the upregulation of estrogen receptor (ER)-α. Here, the higher ALP levels on 
preosteoblasts cultured on TCH-incorporated nanofiber-modified Ti suggest that the 
proposed surface modification with TCH might enhance peri-implant bone formation upon 
implantation. Noteworthy, no visible signs of fiber peeling/detachment from the Ti disks 
were observed throughout the experiments. However, future studies should investigate the 
bonding ability between the TCH-incorporated fibers to titanium prior to its pre-clinical 
evaluation.
CONCLUSION
Collectively, the data suggest that TCH-incorporated polymer nanofibers could function as 
an antimicrobial surface modifier and osteogenic inducer for titanium dental implants.
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(A) Representative SEM images of the distinct PLA:PCL/GEL-based fibers containing 0 
(tetracycline-free), 5, 10, and 25% of TCH; Note the three-dimensional fibrous network with 
micron-sized porosity. (B) The fiber diameter distribution and mean fiber diameter (±SD) 
(inset); Similar uppercase letters next to the (±SD) indicate no significant differences at the 
P 0.05 level. (C) FTIR spectra confirming the incorporation of TCH into the electrospun 
PLA:PCL/GEL polymer-based fibers. Note the presence of characteristic peaks of TCH.
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Drug release (%) profiles from electrospun polymer-based fibers incorporated with distinct 
amounts of tetracycline.
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Mechanical properties of the TCH-free and TCH-incorporated electrospun mats, under dry 
and hydrated testing conditions: (A) Tensile strength, in MPa; (B) Young’s modulus, in 
MPa; and (C) Elongation at break, in %. Asterisks indicate a statistically significant 
difference exists between the two conditions (* p < 0.05). Error bars indicate standard 
deviation of the mean.
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Antimicrobial properties (inhibition zones, in mm) of the TCH-incorporated fibers against 
Aa, Fn, Pg, and Pi. The TCH-incorporated fibers were compared with a known antimicrobial 
solution (i.e., chlorhexidine gluconate at 0.12%, CHX). (B) Cytotoxicity assay data of the 
TCH-incorporated electrospun polymer fibers.
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Antimicrobial properties (inhibition zones, in mm) of the TCH-incorporated nanofiber-
modified Ti disks against Aa, Fn, Pg, and Pi. The TCH-incorporated nanofiber-modified Ti 
disks were compared with CHX and bare (un-modified) Ti disks.
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(A) Cell proliferation (WST-1®) results of MC3T3-E1 on TCH-incorporated nanofiber-
modified Ti disks after 1, 3, 5 and 7 days of cell seeding. (B) Normalized (the results were 
normalized to the total protein and expressed as ng of p-nitrophenol produced per mL per µg 
of protein) ALP activity of cell lysates from pre-osteoblasts (MC3T3-E1) after 1–14 days in 
culture. ALP activity was similar for all groups at days 1 and 3 but a significant increase in 
ALP levels on the Ti disks modified with TCH-incorporated nanofibers (5, 10, and 25 wt.%) 
was noticed on days 7 and 14. ALP activity decreased by day 14 in all the samples. There 
was no statistically significant difference in ALP levels among the TCH-incorporated fibers-
modified Ti.
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Representative SEM images depicting cell proliferation of pre-osteoblasts within the 
nanofiber-modified Ti groups and bare Ti up to day 7.
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